RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
  Anorexia Nervosa
  Anxiety
  Bulimia
  CFS
  Child Psychiatry
  Depression
  Forensic Psychiatry
  Learning-Disabilities
  Mood Disorders
  Neuropsychiatry
  Peri-Natal Psychiatry
  Personality Disorders
  Psychology
  Psychoses
  Psychotherapy
  Sleep Disorders
  Substance Abuse
   Alcohol
   Amphetamine
   Cannabis
   Cocaine
   Opiates
   Smoking
  Suicide
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Cannabis Channel

subscribe to Cannabis newsletter
Latest Research : Psychiatry : Substance Abuse : Cannabis

   EMAIL   |   PRINT
Call for public health campaign on cannabis

Sep 28, 2005 - 7:51:00 AM
“Cannabis is still seen as a risk-free drug despite mounting evidence that it can lead to serious mental health problems, particularly amongst young teenagers, people with a family history of severe mental illness and in long-term users.”

 
[RxPG] The mental healthy charity Rethink on September 23 gave evidence to the Advisory Council on the Mis-use of Drugs, which is considering the classification of cannabis at the request of the Home Secretary and called for a long-term, properly funded public health campaign highlighting the mental health dangers of using cannabis.

It warned the committee that it would be a waste of money to reverse its decision taken 18 months ago to reclassify cannabis from a Class B to Class C drug and would not deter people from using it.

Instead, the charity called for the money to be spent on a massive public education campaign to inform users and potential users of the well-founded mental health dangers of using cannabis at a young age and over a long period of time.

Rethink chief executive Cliff Prior told the committee: “Cannabis is still seen as a risk-free drug despite mounting evidence that it can lead to serious mental health problems, particularly amongst young teenagers, people with a family history of severe mental illness and in long-term users.”

Rethink told the committee that other countries had woken up to the dangers and invested heavily in public health campaigns, despite far lower rates of usage than Britain .

“The government has a responsibility to inform people of the real risks and not hide behind a knee-jerk criminal justice response to what is a mounting health crisis,” said Mr Prior.

The committee heard from one service user about his experience of using cannabis and developing schizophrenia and was presented with testimony from other service users and family members about the impact cannabis had on their lives.



Publication: Rethink. Registered charity number 271028
On the web: Rethink's evidence to the Advisory Council on the Mis-use of Drugs (Word, 237kB)  

Advertise in this space for $10 per month. Contact us today.


Related Cannabis News
Increase in psychotic symptoms predicts relapse to cannabis use
New PET Radiotracer to Visualize Cannabinoid Receptors Developed
Cannabis Based Medicine to be Supplied in Spain
Call for public health campaign on cannabis
Canada approved Cannabis extract Based Drug

Subscribe to Cannabis Newsletter

Enter your email address:


 Additional information about the news article
About Rethink severe mental illness
Rethink is a campaigning membership charity involving people with severe mental illness and carers, with a network of mutual support groups around the country. Rethink is also the largest voluntary sector service provider in mental health, helping 7500 people each day.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)